Back to discover
Drug
Phosphatidylinositols
Research stageEmerging research
Also known as phosphatidylinositol.
2
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Research2019-03-01Journal of microbiology and biotechnology
Cellular survival: a play in three Akts.
Research1999-11-01Genes & development
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Phosphatidylinositols
Aliases & brands
phosphatidylinositol
RxNorm CUI
8217
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Publications over time
19992019
Most influential
Major research themes2
Gastrointestinal Microbiome1Longevity1
Journals, researchers & institutions
Top journals
- Genes & development1
- Journal of microbiology and biotechnology1
Leading researchers
- Bae JS1
- Brunet A1
- Choi CW1
- Chun J1
- Chung JH1
- Datta SR1
- Greenberg ME1
- Han M1
Leading institutions
free-text, unnormalised
- Children's Hospital and Department of Neurobiology1
- Hallym University1
- Institute on Aging1
- Laboratory of Cutaneous Aging Research1
- Multidisciplinary Genome Institute1
- School of Biological Sciences and Inst. of Molecular Biology and Genetics1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Frequently co-studied with Phosphatidylinositols in the research literature.
1 shared paper
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature